5[5]Give TB, Braun PJ, Fishcher. Predicting the presence of plasma heparin using neural networks to analyze cagulation screening assay optical profiles[J]. Computational Biol Ogical Medicine, 1997,46:129 ～ 143.
6[6]Downey C, Kazmi, R, Toh CH. Novel and diagnostically applicable information from optical waveform analysis of blood coagulation in disseminated intravascular coagulation. British Journal of Haematology[J]. 1997, 98:68～73.
7[7]Toh CH, Giles AR. Waveform analysis of clotting test optical profiles in the diagnosis and management of disseminated intravascular coagulation (DIC) [J]. Clin Lab Haem, 2002, 24: 321 ～ 327.
8[8]Steven A J, Chamuleau, Robbert J de Winter. Activated partialthromboplati time (aPTT) monitoring to achieve therapeutic anticoagulation befor and after introducing a nomogram for adjunctive hepar in treatmeen with thromobolytic therapy for acute myocardial infarction[J]. Inter Journal of Cardiology, 1998, 67,241 ～246.
9[9]Hemker HC, Giesen P, Aidieri R, et al. The calibrated automated thrombogram (CAT) :An universal routine test for hyper and hypocoagulability[J]. Pathophysiol Haemost Thromb, 2002, 32:249 ～253.
10[11]Fabera J, Loddera F, Kesselsb J, et al. Thrombin generation in platelet-rich plasmaas a tool for the detection of hypercoagulability in youg stroke patients [J]. Pathophysiol Haemost Thromb, 2003,33:52 ～ 58.
